다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Cadrenal Therapeutics Inc (CVKD)
Cadrenal Therapeutics Inc (CVKD) 뉴스

CVKD

Cadrenal Therapeutics (CVKD)

Cadrenal Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CVKD

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/09	22:44	Business Wire	Cadrenal Therapeutics to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/12/31	22:00	Business Wire	Cadrenal Therapeutics Provides 2024 Year-End Company Update, Reinforcing Clinical Development Plan for Tecarfarin in LVAD and Other Rare Cardiovascular Indications	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/12/24	06:44	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/12/21	07:28	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/12/18	23:00	Business Wire	Cadrenal Therapeutics Gears Up for the 43rd Annual J.P. Morgan Healthcare Conference Week with Event Participation and Investor/Partner Meetings	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/11/26	06:53	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/11/25	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/11/19	23:00	PR Newswire (US)	Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/11/15	06:05	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/11/14	23:00	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/11/12	23:00	PR Newswire (US)	CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/11/08	06:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/11/07	23:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/11/07	23:00	PR Newswire (US)	CADRENAL THERAPEUTICS PROVIDES THIRD-QUARTER CORPORATE UPDATE	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/11/05	06:41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/11/04	23:13	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/11/04	23:13	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/11/02	09:00	PR Newswire (US)	Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/10/24	22:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/10/24	22:00	PR Newswire (US)	Cadrenal Therapeutics Raises $5.1 Million via At-The-Market Facility	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/10/23	22:00	PR Newswire (US)	CADRENAL THERAPEUTICS JOINS CORPORATE COUNCIL OF ANTICOAGULATION FORUM	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/10/05	05:15	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/09/26	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/09/24	05:15	PR Newswire (US)	Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor Conference	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/09/06	05:59	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/08/22	22:00	PR Newswire (US)	Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/08/20	22:00	PR Newswire (US)	Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/08/20	19:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/08/16	19:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CVKD	Cadrenal Therapeutics Inc
2024/08/14	22:00	PR Newswire (US)	Cadrenal Therapeutics to Present at Upcoming Investor Conferences	NASDAQ:CVKD	Cadrenal Therapeutics Inc

검색 관련기사 보기:NASDAQ:CVKD

1 2 3 4 다음 >>

DIFN28V28 - 07/2028

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관